Publications by authors named "George Pepper"

Claim this Profile
C
Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?
Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, Michael Levy, E Ann Yeh, George Pepper

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices.
Edward J D Webb, David Meads, Ieva Eskytė, Helen L Ford, Hilary L Bekker, George Pepper

Patient· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis.
Charlotte R Wicks, Rob Sloan, Sophie DiMauro, Emily L Thompson, Sam Billington, George Pepper

Mult Scler Relat Disord· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments.
Edward J D Webb, David Meads, Ieva Eskytė, Helen L Ford, Hilary L Bekker, George Pepper

Patient· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis.
Ana Manzano, Ieva Eskytė, Helen L Ford, Hilary L Bekker, Barbara Potrata, George Pepper

Patient Educ Couns· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus on quality standards for brain health-focused care in multiple sclerosis.
Jeremy Hobart, Amy Bowen, George Pepper, Harriet Crofts, Lucy Eberhard

Mult Scler· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis.
Ieva Eskyte, Ana Manzano, George Pepper, Sue Pavitt, Helen Ford

Mult Scler Relat Disord· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
Zhifeng Mao, César Álvarez-Gonzalez, Stefania De Trane, Ozlem Yildiz, Christo Albor, George Pepper

Mult Scler J Exp Transl Clin· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

Mult Scler Relat Disord· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain health: time matters in multiple sclerosis.
Gavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, Jeremy Hobart, Gisela Kobelt, George Pepper

Mult Scler Relat Disord· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MSer - A new, neutral descriptor for someone with multiple sclerosis.
David Baker, George Pepper, Freddie Yauner, Gavin Giovannoni

Mult Scler Relat Disord· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis